In late 2025, SELLAS Life Sciences Group reported encouraging Phase 2 data for SLS009 in combination with azacitidine and venetoclax in relapsed or refractory acute myeloid leukemia and confirmed that ...
One word would describe 19-year-old Ethan Ruiz’s reaction to his newly renovated home: “Gobsmacked.” “I don’t know how you ...
New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...
The Emmaus High community is raising funds for childhood cancer research in advance of its March 13 “Shave for the Brave” ...